跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-BETAHISTINE
Authorized
STANDARD
MINT-BETAHISTINE
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b6d0f43a09a04cb8
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
b6d0f43a09a04cb8
Drug Approval Canada Name
MINT-BETAHISTINE
Product Name
MINT-BETAHISTINE
Status
Marketed
Status Date
2023-10-31
Original Market Date
2023-10-31
Din
02538156
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:92.00
Atc Original
N07CA01 BETAHISTINE
Atc Name
n 07 ca 01
Aig Number
0103555004
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
BETAHISTINE HYDROCHLORIDE
24 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b6d0f43a09a04cb8
Type
Standard
Back to Health Canada Approvals
MINT-BETAHISTINE - Health Canada Drug Approval Details